Literature DB >> 20697002

Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.

Steven J Budd1, Hilary Thompson, M Elizabeth Hartnett.   

Abstract

OBJECTIVE: To study the effects of oxygen fluctuations on rat vascular endothelial growth factor (VEGF), VEGF receptor 1(VEGFR1), and VEGFR2 in a model of retinopathy of prematurity (ROP).
METHODS: Retinas at several postnatal days (p) were analyzed for VEGF splice variants, VEGFR1 and VEGFR2 messenger RNAs (mRNAs) using real-time polymerase chain reaction or for VEGF protein using enzyme-linked immunosorbent assay.
RESULTS: Older developmental age was associated with VEGFR1 (P < .001), VEGF(120) (P < .001), and VEGF(188) (P = .03) mRNA overexpression. Expression of VEGFR2 and VEGF(164) mRNAs were associated with older age (P < .001) or exposure to the ROP model (P = .02 and P < .001, respectively). Expression of VEGF protein was greater at p14, when 30% avascular retina existed in the ROP model, compared with room air, when no avascular retina existed, and at p18, when intravitreous neovascularization existed in the model but not in room air (P < .001 for both).
CONCLUSIONS: Unlike models of oxygen-induced retinopathy that describe ROP before implementation of oxygen regulation, the ROP model re-creates oxygen stresses relevant to preterm infants with severe ROP today. Expression of VEGF(164) and VEGFR2 mRNAs and VEGF protein were increased in association with the ROP model and older developmental age and at time points when not only intravitreous neovascularization but also avascular retina were present in the ROP model and not in room air. Clinical Relevance Regulation of VEGF may have a role in the development of avascular retina and intravitreous neovascularization in some forms of severe ROP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697002      PMCID: PMC3723353          DOI: 10.1001/archophthalmol.2010.158

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  53 in total

1.  Specific involvement of SRC family kinase activation in the pathogenesis of retinal neovascularization.

Authors:  Xiang Q Werdich; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

2.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

3.  Attenuation of retinal vascular development and neovascularization in transgenic mice over-expressing thrombospondin-1 in the lens.

Authors:  Zhifeng Wu; Shoujian Wang; Christine M Sorenson; Nader Sheibani
Journal:  Dev Dyn       Date:  2006-07       Impact factor: 3.780

4.  HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin.

Authors:  Masanobu Morita; Osamu Ohneda; Toshiharu Yamashita; Satoru Takahashi; Norio Suzuki; Osamu Nakajima; Shimako Kawauchi; Masatsugu Ema; Shigeki Shibahara; Tetsuo Udono; Koji Tomita; Makoto Tamai; Kazuhiro Sogawa; Masayuki Yamamoto; Yoshiaki Fujii-Kuriyama
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

5.  Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  2003-12

6.  Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening.

Authors:  Ann Hellström; Anna-Lena Hård; Eva Engström; Aimon Niklasson; Eva Andersson; Lois Smith; Chatarina Löfqvist
Journal:  Pediatrics       Date:  2009-03-16       Impact factor: 7.124

7.  Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation.

Authors:  Katie Bentley; Holger Gerhardt; Paul A Bates
Journal:  J Theor Biol       Date:  2007-09-19       Impact factor: 2.691

8.  Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Authors:  Kazuaki Nishijima; Yin-Shan Ng; Lichun Zhong; John Bradley; William Schubert; Nobuo Jo; Jo Akita; Steven J Samuelsson; Gregory S Robinson; Anthony P Adamis; David T Shima
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  11 in total

1.  Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity.

Authors:  B J Lee; J H Kim; H Heo; Y S Yu
Journal:  Eye (Lond)       Date:  2012-06-15       Impact factor: 3.775

2.  VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis.

Authors:  Zhihong Yang; Haibo Wang; Yanchao Jiang; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2014-03-12       Impact factor: 4.307

3.  Breaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration.

Authors:  Haibo Wang; Erika S Wittchen; M Elizabeth Hartnett
Journal:  Eye Brain       Date:  2011-09-27

Review 4.  Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Clin Perinatol       Date:  2014-09-23       Impact factor: 3.430

5.  VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.

Authors:  Haibo Wang; Grace Byfield; Yanchao Jiang; George Wesley Smith; Manabu McCloskey; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2012-01-09       Impact factor: 4.307

6.  Genetic polymorphisms of vascular endothelial growth factor and risk for retinopathy of prematurity in South of Iran.

Authors:  Zahra Asadi Kalmeh; Negar Azarpira; Mahnaz Mosallaei; Hamid Hosseini; Zahra Malekpour
Journal:  Mol Biol Rep       Date:  2013-05-04       Impact factor: 2.316

7.  Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity.

Authors:  Haibo Wang; George W Smith; Zhihong Yang; Yanchao Jiang; Manabu McCloskey; Kenneth Greenberg; Pete Geisen; William D Culp; John Flannery; Tal Kafri; Scott Hammond; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2013-09       Impact factor: 4.307

8.  Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity.

Authors:  John S Hartmann; Hilary Thompson; Haibo Wang; Shami Kanekar; Wei Huang; Steven J Budd; M Elizabeth Hartnett
Journal:  Mol Vis       Date:  2011-06-10       Impact factor: 2.367

9.  Discovering Mechanisms in the Changing and Diverse Pathology of Retinopathy of Prematurity: The Weisenfeld Award Lecture.

Authors:  M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-04-01       Impact factor: 4.799

10.  Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.

Authors:  Haibo Wang; Zhihong Yang; Yanchao Jiang; M Elizabeth Hartnett
Journal:  Mol Vis       Date:  2014-03-03       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.